Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study
- PMID: 17266064
- DOI: 10.1002/art.22473
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study
Abstract
Objective: To investigate the proxy-reported health-related quality of life (HRQOL) and its determinants in patients with juvenile idiopathic arthritis (JIA).
Methods: In this multinational, multicenter, cross-sectional study, HRQOL of patients with JIA was assessed through the Child Health Questionnaire (CHQ) and was compared with that of healthy children of similar age from the same geographic area. Potential determinants of HRQOL included demographic data, physician's and parent's global assessments, measures of joint inflammation, Childhood Health Assessment Questionnaire (CHAQ), and erythrocyte sedimentation rate.
Results: A total of 6,639 participants (3,324 with JIA and 3,315 healthy) were enrolled from 32 countries. The mean +/- SD physical and psychosocial summary scores of the CHQ were significantly lower in patients with JIA than in healthy children (physical: 44.5 +/- 10.6 versus 54.6 +/- 4.0, P < 0.0001; psychosocial: 47.6 +/- 8.7 versus 51.9 +/- 7.5, P < 0.0001), with the physical well-being domain being most impaired. Patients with persistent oligoarthritis had better HRQOL compared with other subtypes, whereas HRQOL was similar across patients with systemic arthritis, polyarthritis, and extended oligoarthritis. A CHAQ score >1 and a pain intensity rating >3.4 cm on a 10-cm visual analog scale were the strongest determinants of poorer HRQOL in the physical and psychosocial domains, respectively.
Conclusion: We found that patients with JIA have a significant impairment of their HRQOL compared with healthy peers, particularly in the physical domain. Physical well-being was mostly affected by the level of functional impairment, whereas the intensity of pain had the greatest influence on psychosocial health.
Similar articles
-
Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.Arthritis Rheum. 2009 Apr 15;61(4):509-17. doi: 10.1002/art.24343. Arthritis Rheum. 2009. PMID: 19333974
-
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study.Rheumatology (Oxford). 2007 Feb;46(2):314-20. doi: 10.1093/rheumatology/kel218. Epub 2006 Jul 28. Rheumatology (Oxford). 2007. PMID: 16877459
-
Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire.J Rheumatol. 2003 Jul;30(7):1602-10. J Rheumatol. 2003. PMID: 12858465
-
Quality of life issues in pediatric immune-mediated inflammatory disease.J Rheumatol Suppl. 2011 Nov;88:20-5. doi: 10.3899/jrheum.110905. J Rheumatol Suppl. 2011. PMID: 22045974 Review.
-
Measuring clinical response and remission in juvenile idiopathic arthritis.Curr Opin Rheumatol. 2007 Sep;19(5):471-6. doi: 10.1097/BOR.0b013e32825a6a68. Curr Opin Rheumatol. 2007. PMID: 17762613 Review.
Cited by
-
Health-related quality of life in children with sickle cell disease using the child health questionnaire.J Pediatr Health Care. 2014 Jan-Feb;28(1):14-22. doi: 10.1016/j.pedhc.2012.09.004. Epub 2012 Nov 8. J Pediatr Health Care. 2014. PMID: 23140759 Free PMC article.
-
Oral health-related quality of life in 4-16-year-olds with and without juvenile idiopathic arthritis.BMC Oral Health. 2022 Sep 6;22(1):387. doi: 10.1186/s12903-022-02400-1. BMC Oral Health. 2022. PMID: 36068497 Free PMC article.
-
Burden of childhood-onset arthritis.Pediatr Rheumatol Online J. 2010 Jul 8;8:20. doi: 10.1186/1546-0096-8-20. Pediatr Rheumatol Online J. 2010. PMID: 20615240 Free PMC article.
-
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.Rheumatol Int. 2015 Feb;35(2):323-6. doi: 10.1007/s00296-014-3103-2. Epub 2014 Aug 3. Rheumatol Int. 2015. PMID: 25086629
-
The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people.Pediatr Rheumatol Online J. 2015 Dec 12;13:58. doi: 10.1186/s12969-015-0052-6. Pediatr Rheumatol Online J. 2015. PMID: 26653415 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
